Hikma Pharmaceuticals Plc Director/PDMR Shareholding (1838Q)
04 June 2018 - 7:29PM
UK Regulatory
TIDMHIK
RNS Number : 1838Q
Hikma Pharmaceuticals Plc
04 June 2018
Notification and public disclosure of transactions by persons
discharging managerial responsibilities
Said Darwazah
1 Details of the person discharging managerial
responsibilities / person closely associated
--- ---------------------------------------------------------------
a) Name Said Darwazah
--- --------------------- ----------------------------------------
2 Reason for the notification
--- ---------------------------------------------------------------
a) Position/status Executive Chairman
--- --------------------- ----------------------------------------
b) Initial notification Initial notification
/Amendment
--- --------------------- ----------------------------------------
3 Details of the issuer, emission allowance market
participant, auction platform, auctioneer or
auction monitor
--- ---------------------------------------------------------------
a) Name Hikma Pharmaceuticals PLC
--- --------------------- ----------------------------------------
b) LEI 549300BNS685UXH4JI75
--- --------------------- ----------------------------------------
4 Details of the transaction(s): section to be
repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date;
and (iv) each place where transactions have
been conducted
--- ---------------------------------------------------------------
a) Description Description: Ordinary shares of 10
of the financial pence each
instrument, ID Code: GB00B0LCW083
type of instrument
and identification
code
--- --------------------- ----------------------------------------
b) Nature of Release of a pledge by Darhold Limited
the transaction over 1,800,000 Ordinary Shares of
10 pence each in Hikma Pharmaceuticals
PLC in favour of Europe Arab Bank
Plc. The Executive Chairman is a
director of and shareholder in Darhold
Limited with an equity interest of
21.76%.
--- --------------------- ----------------------------------------
c) Price(s) and Price(s): GBP0.00p
volume(s) Volume(s): 1,800,000
--- --------------------- ----------------------------------------
d) Aggregated Aggregated volume: 1,800,000
information Price: GBP0.00p
--- --------------------- ----------------------------------------
e) Date of the 4 June 2018
transaction
--- --------------------- ----------------------------------------
f) Place of the Amman
transaction
--- --------------------- ----------------------------------------
Mazen Darwazah
1 Details of the person discharging managerial
responsibilities / person closely associated
--- ---------------------------------------------------------------
a) Name Mazen Darwazah
--- --------------------- ----------------------------------------
2 Reason for the notification
--- ---------------------------------------------------------------
a) Position/status Executive Vice Chairman
--- --------------------- ----------------------------------------
b) Initial notification Initial notification
/Amendment
--- --------------------- ----------------------------------------
3 Details of the issuer, emission allowance market
participant, auction platform, auctioneer or
auction monitor
--- ---------------------------------------------------------------
a) Name Hikma Pharmaceuticals PLC
--- --------------------- ----------------------------------------
b) LEI 549300BNS685UXH4JI75
--- --------------------- ----------------------------------------
4 Details of the transaction(s): section to be
repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date;
and (iv) each place where transactions have
been conducted
--- ---------------------------------------------------------------
a) Description Description: Ordinary shares of 10
of the financial pence each
instrument, ID Code: GB00B0LCW083
type of instrument
and identification
code
--- --------------------- ----------------------------------------
b) Nature of Release of a pledge by Darhold Limited
the transaction over 1,800,000 Ordinary Shares of
10 pence each in Hikma Pharmaceuticals
PLC in favour of Europe Arab Bank
Plc. The Executive Vice Chairman
is a director of and shareholder
in Darhold Limited with an equity
interest of 10.96%.
--- --------------------- ----------------------------------------
c) Price(s) and Price(s): GBP0.00p
volume(s) Volume(s): 1,800,000
--- --------------------- ----------------------------------------
d) Aggregated Aggregated volume: 1,800,000
information Price: GBP0.00p
--- --------------------- ----------------------------------------
e) Date of the 4 June 2018
transaction
--- --------------------- ----------------------------------------
f) Place of the Amman
transaction
--- --------------------- ----------------------------------------
Mohammed 'Ali' Al-Husry
1 Details of the person discharging managerial
responsibilities / person closely associated
--- ----------------------------------------------------------------
a) Name Mohammed 'Ali' Al-Husry
--- --------------------- -----------------------------------------
2 Reason for the notification
--- ----------------------------------------------------------------
a) Position/status Non-Executive Director
--- --------------------- -----------------------------------------
b) Initial notification Initial notification
/Amendment
--- --------------------- -----------------------------------------
3 Details of the issuer, emission allowance market
participant, auction platform, auctioneer or
auction monitor
--- ----------------------------------------------------------------
a) Name Hikma Pharmaceuticals PLC
--- --------------------- -----------------------------------------
b) LEI 549300BNS685UXH4JI75
--- --------------------- -----------------------------------------
4 Details of the transaction(s): section to be
repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date;
and (iv) each place where transactions have
been conducted
--- ----------------------------------------------------------------
a) Description Description: Ordinary shares of 10
of the financial pence each
instrument, ID Code: GB00B0LCW083
type of instrument
and identification
code
--- --------------------- -----------------------------------------
b) Nature of Release of a pledge by Darhold Limited
the transaction over 1,800,000 Ordinary Shares of
10 pence each in Hikma Pharmaceuticals
PLC in favour of Europe Arab Bank
Plc. The Non-Executive Director is
a director of and shareholder in
Darhold Limited with an equity interest
of 8.05%.
--- --------------------- -----------------------------------------
c) Price(s) and Price(s): GBP0.00p
volume(s) Volume(s): 1,800,000
--- --------------------- -----------------------------------------
d) Aggregated Aggregated volume: 1,800,000
information Price: GBP0.00p
--- --------------------- -----------------------------------------
e) Date of the 4 June 2018
transaction
--- --------------------- -----------------------------------------
f) Place of the Amman
transaction
--- --------------------- -----------------------------------------
Peter Speirs
Company Secretary, responsible for releasing this
announcement
+44 (0) 20 7399 2760
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHGCGDLRDGBGIS
(END) Dow Jones Newswires
June 04, 2018 05:29 ET (09:29 GMT)
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Apr 2024 to May 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From May 2023 to May 2024
